Press releases

9/6/2013

BAXTER COMPLETES ACQUISITION OF GAMBRO AB AND ENHANCES GLOBAL LEADERSHIP IN RENAL THERAPIES

Deerfield, Ill., September 6, 2013 – Baxter International Inc. (NYSE: BAX) today announced that the company has successfully com…

1/24/2013

Gambro MARS® receives FDA 510(k) clearance for treatment of Hepatic Encephalopathy

Gambro announced today that the U.S. Food and Drug Administration (FDA) has expanded the cleared indications for its Molecular A…

12/4/2012

BAXTER ENHANCES RENAL THERAPIES PORTFOLIO WITH ACQUISITION OF GAMBRO

Acquisition Expands Baxter’s Role as Global Provider of Dialysis Products Transaction Supports Accelerated Sales and Earnings Gr…

10/15/2012

Gambro and Novalung join forces to address unmet medical need of CO2 removal in the Intensive Care Unit

Partnership to integrate Novalung’s membrane gas exchange technology into the Prismaflex platform adding CO2 removal to its ther…

5/24/2012

Gambro at the 49th ERA-EDTA Congress May 24-27, 2012 in Paris - France

ERA-EDTA is one of the most important congresses within the field of clinical nephrology, dialysis, renal transplantation and re…

4/16/2012

Gambro introduces SelectBag® Citrate to improve quality of life for hemodialysis patients

Gambro introduces SelectBag® Citrate to improve quality of life for hemodialysis patients. Improving quality of life for hemodia…

2/6/2012

BMBF* funds a research project coordinated by Gambro to investigate Chronic Inflammation in ESRD patients

A research consortium headed by Gambro Dialysatoren GmbH in Hechingen (Germany), consisting of researchers from different discip…

10/6/2011

Gambro introduces FleXitrate — the complete citrate-calcium offering for Continuous Renal Replacement Therapy (CRRT)

Effective CRRT is largely determined by adequate anticoagulation of the extracorporeal circuit. With FleXitrate, Gambro makes pe…

7/15/2011

Gambro celebrates 25 years of catheter development in its manufacturing plant in Hechingen, Germany

It all started in 1984, with the production of single lumen catheters. Today, more than 70 employees work at Gambro Kathetertech…

7/5/2011

Gambro Industry Symposium: “Therapy options for individualized quality-assured dialysis” at the ERA-EDTA Congress in Prague

On June 24, 2011, Gambro hosted a Lunch Symposium at the ERA-EDTA Congress in Prague which attracted great interest from the Con…